Magnesium in a Polyethylene Glycol Formulation Provides Neuroprotection after Unilateral Cervical Spinal Cord Injury

Spine

Volumn 35, Issue 23, 2010, Pages 2041-2048

  Lee, Jae H T ^a   Roy, Josee ^b   Moon Sohn, Hong ^c   Cheong, Mi ^d   Liu, Jie ^a   Stammers, Anthea T ^a   Tetzlaff, Wolfram ^a   Kwon, Brian K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Medtronic   (United States)

^c Chosun University   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

cervical spinal cord injury; magnesium chloride; neuroprotection; polyethylene glycol

Indexed keywords

MACROGOL; MAGNESIUM CHLORIDE; NEUROPROTECTIVE AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL SPINAL CORD INJURY; CERVICAL SPINE; CONTROLLED STUDY; CONTUSION; DRUG FORMULATION; EXPERIMENTAL STUDY; FORELIMB; GRAY MATTER; HISTOLOGY; HUMAN; MALE; MULTIPLE TRAUMA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RAT; WHITE MATTER;

ANIMALS; CERVICAL VERTEBRAE; GAIT; MAGNESIUM CHLORIDE; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; POLYETHYLENE GLYCOLS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 78149284730     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181d2d6c5     Document Type: Article

References (49)

1. National Spinal Cord Injury Statistical Center. Spinal cord injury. Facts and figures at a glance. J Spinal Cord Med 2008;31:357-8.
2. Dumont RJ, Okonkwo DO, Verma S, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001;24:254-64.
3. Dumont RJ, Verma S, Okonkwo DO, et al. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol 2001;24:265-79.
4. Kwon BK, Tetzlaff W, Grauer JN, et al. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004;4:451-64.
5. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008;55:363-89.
6. Gok B, Okutan O, Beskonakli E, et al. Effects of magnesium sulphate following spinal cord injury in rats. Chin J Physiol 2007;50:93-7.
7. Hoane MR. Assessment of cognitive function following magnesium therapy in the traumatically injured brain. Magnes Res 2007;20:229-36.
8. Schouten JW. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care 2007;13:134-42.
9. Fu ES, Tummala RP. Neuroprotection in brain and spinal cord trauma. Curr Opin Anaesthesiol 2005;18:181-7.
10. Suzer T, Coskun E, Islekel H, et al. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Spinal Cord 1999;37:480-4.
11. Nurko S, Youssef NN, Sabri M, et al. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr 2008;153:254-61.
12. Aronow WS. Heart failure-complicating acute myocardial infarction. Heart Fail Clin 2007;3:465-75.
13. Muir KW, Lees KR, Ford I, et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004;363:439-45.
14. Saver JL, Kidwell C, Eckstein M, et al. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004;35:e106-8.
15. Temkin NR, Anderson GD, Winn HR, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 2007;6:29-38.
16. Zhang L, Rzigalinski BA, Ellis EF, et al. Reduction of voltage-dependent Mg2 + blockade of NMDA current in mechanically injured neurons. Science 1996;274:1921-3.
17. Vink R, Cernak I. Regulation of intracellular free magnesium in central nervous system injury. Front Biosci 2000;5:D656-65.
18. Vink R, Yum SW, Lemke M, et al. Traumatic spinal cord injury in rabbits decreases intracellular free magnesium concentration as measured by 31P MRS. Brain Res 1989;490:144-7.
19. Vink R, McIntosh TK, Demediuk P, et al. Decline in intracellular free Mg2 + is associated with irreversible tissue injury after brain trauma. J Biol Chem 1988;263:757-61.
20. Kaptanoglu E, Beskonakli E, Okutan O, et al. Effect of magnesium sulphate in experimental spinal cord injury: evaluation with ultrastructural findings and early clinical results. J Clin Neurosci 2003;10:329-34.
21. Ozdemir M, Cengiz SL, Gurbilek M, et al. Effects of magnesium sulfate on spinal cord tissue lactate and malondialdehyde levels after spinal cord trauma. Magnes Res 2005;18:170-4.
22. Kaptanoglu E, Beskonakli E, Solaroglu I, et al. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev 2003;26:283-7.
23. Solaroglu I, Kaptanoglu E, Okutan O, et al. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. Surg Neurol 2005;64(suppl 2):S17-21.
24. Poschel KA, Bucha E, Esslinger HU, et al. Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure. Kidney Int 2000;58:2478-84.
25. Kwon BK, Roy J, Lee JH, et al. Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: pre-clinical refinement and optimization. J Neurotrauma 2009;26:1379-93.
26. Metz GA, Whishaw IQ. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore-and hindlimb stepping, placing, and co-ordination. J Neurosci Methods 2002; 115:169-79.
27. Soblosky JS, Song JH, Dinh DH. Graded unilateral cervical spinal cord injury in the rat: evaluation of forelimb recovery and histological effects. Behav Brain Res 2001;119:1-13.
28. Soblosky JS, Colgin LL, Chorney-Lane D, et al. Ladder beam and camera video recording system for evaluating forelimb and hindlimb deficits after sensorimotor cortex injury in rats. J Neurosci Methods 1997;78:75-83.
29. Schallert T, Fleming SM, Leasure JL, et al. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000; 39:777-87.
30. Rabchevsky AG, Fugaccia I, Sullivan PG, et al. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 2001;18:513-22.
31. Ditor DS, John SM, Roy J, et al. Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J Neurosci Res 2007;85:1458-67.
32. Jain A, Jain SK. PEGylation: an approach for drug delivery. A review. Crit Rev Ther Drug Carrier Syst 2008;25:403-47.
33. Gensel JC, Tovar CA, Hamers FP, et al. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J Neurotrauma 2006;23:36-54.
34. Kwon BK, Borisoff JF, Tetzlaff W. Molecular targets for therapeutic intervention after spinal cord injury. Mol Interv 2002;2:244-58.
35. McKenna JE, Prusky GT, Whishaw IQ. Cervical motoneuron topography reflects the proximodistal organization of muscles and movements of the rat forelimb: a retrograde carbocyanine dye analysis. J Comp Neurol 2000;419: 286-96.
36. Noble LJ, Wrathall JR. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp Neurol 1985;88:135-49.
37. Noble LJ, Wrathall JR. Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp Neurol 1989;103:34-40.
38. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retro-gradely labeled neurons after experimental spinal cord injury. Exp Neurol 1995;132:220-8.
39. Pençe S. Paw preference in rats. J Basic Clin Physiol Pharmacol 2002;13: 41-9.
40. Tang AC, Verstynen T. Early life environment modulates 'handedness' in rats. Behav Brain Res 2002;131:1-7.
41. Whishaw IQ, Pellis SM. The structure of skilled forelimb reaching in the rat: a proximally driven movement with a single distal rotatory component. Behav Brain Res 1990;41:49-59.
42. Stackhouse SK, Murray M, Shumsky JS. Effect of cervical dorsolateral funi-culotomy on reach-to-grasp function in the rat. J Neurotrauma 2008;25: 1039-47.
43. Girgis J, Merrett D, Kirkland S, et al. Reaching training in rats with spinal cord injury promotes plasticity and task specific recovery. Brain 2007;130: 2993-3003.
44. Anderson KD, Gunawan A, Steward O. Spinal pathways involved in the control of forelimb motor function in rats. Exp Neurol 2007;206:318-31.
45. Anderson KD, Gunawan A, Steward O. Quantitative assessment of forelimb motor function after cervical spinal cord injury in rats: relationship to the corticospinal tract. Exp Neurol 2005;194:161-74.
46. Hamers FP, Lankhorst AJ, van Laar TJ, et al. Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma 2001;18:187-201.
47. Hamers FP, Koopmans GC, Joosten EA. Cat Walk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 2006;23:537-48.
48. Jones TA, Schallert T. Overgrowth and pruning of dendrites in adult rats recovering from neocortical damage. Brain Res 1992;581:156-60.
49. Liu Y, Kim D, Himes BT, et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 1999;19:4370-87.